V. Cool

发表

Barium ion-selective electrode based on a new neutral carrier complex

J. Viré, A. Bouklouze, V. Cool, 1993 .

A novel PET tracer for evaluation of gene therapy

S. Goldman, M. Monclus, V. Cool, 1996 .

Development of a positron emission tomography radiopharmaceutical for imaging thymidine kinase gene expression: Synthesis and in vitro evaluation of 9-{3-[18F] Fluoro-1-hydroxy-2-propoxymethyl guanine

A. Luxen, S. Goldman, P. Damhaut, 1997 .

Comparative in vitro and in vivo cytotoxic activity of (E)-5-(2-bromovinyl)-2′-deoxyuridine (BVDU) and its arabinosyl derivative, (E)-5-(2-bromovinyl)-1-β-D-arabinofuranosyluracil (BVaraU), against tumor cells expressing either the Varicella zoster or the Herpes simplex virus thymidine kinase

T. Velu, B. Degrève, J. Balzarini, 2000, Cancer Gene Therapy.

Curative potential of herpes simplex virus thymidine kinase gene transfer in rats with 9L gliosarcoma.

S. Goldman, B. Pirotte, J. Brotchi, 1996, Human gene therapy.

Granulocyte macrophage-colony stimulating factor gene transfer to induce a protective anti-tumoral immune response against the 9L rat gliosarcoma model.

J. Brotchi, O. De Witte, T. Velu, 2002, International Journal of Oncology.

Highly Successful Therapeutic Vaccinations Combining Dendritic Cells and Tumor Cells Secreting Granulocyte Macrophage Colony-stimulating Factor

C. Bruyns, T. Velu, G. Driessens, 2004, Cancer Research.

The role of cellular- and prodrug-associated factors in the bystander effect induced by the Varicella zoster and Herpes simplex viral thymidine kinases in suicide gene therapy

T. Velu, C. Grignet-Debrus, C. Calberg‐Bacq, 2000, Cancer Gene Therapy.